Around 180,000 elderly patients with Alzheimer’s and similar memory-loss illnesses are taking some form of antipsychotic medication to control symptoms such as aggression.
But the drugs, dubbed ‘chemical cosh’ due to their dangerous side-effects, have been blamed for causing 1,800 deaths a year.
They are also known to worsen symptoms of confusion, dizziness and unsteadiness and often lead to falls.
Ministers are concerned that many GPs hand out the drugs ‘inappropriately’ without considering other forms of care and treatment.
Under new guidelines, family doctors are being told to review every single patient taking one of these drugs to consider whether it is necessary.
There are concerns the drugs are being prescribed simply to sedate patients to make their carers’ jobs easier.
Campaigners, including the Alzheimer’s Society charity, claim there are far more effective and less harmful treatments.
This week scientists demonstrated that simple painkillers including antipsychotics were just as effective – and far less harmful.
Other forms of therapy such as crosswords, singing and problem-solving exercises to keep patients’ minds active are also thought to be effective.
Nearly a quarter of the 750,000 people in Britain with some form of dementia are prescribed an antipsychotic drug. Numerous studies have shown that patients who take them over a long period are twice as likely to die early as those who do not.
Antipsychotics can increase symptoms of dementia.
According to the Alzheimer’s Society, five people die every day as a result of these drugs and another four come to some form of harm.
Quicker: Care Minister Paul Burstow (pictured) wants people with signs of dementia to be tested and diagnosed earlier
Care Services Minister Paul Burstow said: ‘With early diagnosis and good care, people with dementia can continue to live well for many years.
‘But for this to happen, it is vital that services are designed and delivered to meet the needs of individuals and their local communities.
‘This is why we want to devolve power to clinicians and patients but we also recognise that local commissioners need to be supported with expert tools and advice.’
Tidak ada komentar:
Posting Komentar